scanX
Home
Fairdeal Corporation

Fairdeal Corporation

538.65
-0.90
(-0.17%)
Market Cap (₹ Cr.)
₹8,782
52 Week High
658.85
Book Value
₹129
52 Week Low
343.30
PE Ratio
27.93
PB Ratio
4.19
PE for Sector
38.75
PB for Sector
4.65
ROE
9.78 %
ROCE
18.55 %
Dividend Yield
0.00 %
EPS
₹19.31
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
11.51 %
Net Income Growth
57.39 %
Cash Flow Change
42.52 %
ROE
48.70 %
ROCE
43.50 %
EBITDA Margin (Avg.)
31.22 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
231
272
273
231
251
277
296
225
265
251
316
261
297
299
283
266
284
347
370
350
374
334
394
368
334
468
427
354
348
512
475
425
441
560
507
478
475
652
Expenses
177
197
198
179
186
202
197
183
196
201
215
197
242
217
215
199
231
263
271
235
304
204
266
263
274
331
324
298
319
413
395
360
377
410
401
370
396
482
EBITDA
54
75
75
51
66
75
99
42
70
49
101
64
55
82
68
68
53
83
99
115
69
130
128
104
59
137
103
57
29
99
80
65
64
150
106
107
79
170
Operating Profit %
18 %
23 %
22 %
18 %
24 %
24 %
30 %
17 %
22 %
15 %
30 %
21 %
11 %
24 %
20 %
21 %
14 %
22 %
21 %
26 %
8 %
33 %
29 %
21 %
12 %
26 %
18 %
13 %
5 %
16 %
11 %
11 %
13 %
23 %
16 %
18 %
13 %
23 %
Depreciation
9
8
9
8
8
8
8
9
9
9
9
8
8
9
9
7
8
9
10
9
9
9
10
9
9
10
9
9
9
9
10
10
10
10
10
10
10
11
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
45
66
66
43
57
66
90
33
61
40
92
56
47
73
59
60
45
73
89
105
59
120
118
94
49
127
93
47
19
89
69
54
53
139
95
96
67
158
Tax
11
19
18
11
16
19
25
11
12
12
26
14
15
22
17
16
12
22
26
30
5
31
27
19
8
31
19
15
3
24
18
12
15
31
22
20
13
36
Net Profit
34
47
48
32
41
49
67
22
49
29
65
43
32
51
43
44
34
52
63
73
58
91
91
71
42
100
74
32
14
73
51
39
37
109
72
78
48
115
EPS in ₹
1.91
2.46
2.70
1.80
2.33
2.75
3.77
1.24
2.76
1.65
3.65
2.40
1.77
2.93
2.47
2.51
1.93
3.00
3.64
4.26
3.40
5.30
5.33
4.18
2.49
5.93
4.36
1.87
0.85
4.37
3.07
2.38
2.24
6.54
4.36
4.81
2.97
7.06
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,140
1,259
1,459
1,488
1,625
1,806
1,943
2,254
2,335
2,459
Fixed Assets
381
671
674
670
678
670
685
701
695
676
Current Assets
498
520
703
708
729
923
924
989
1,024
1,055
Capital Work in Progress
29
20
6
13
12
24
19
104
198
261
Investments
272
325
491
472
585
665
790
886
806
850
Other Assets
457
243
287
333
349
447
448
563
637
672
Total Liabilities
210
182
196
225
192
264
221
306
355
361
Current Liabilities
186
162
177
207
177
245
202
271
311
308
Non Current Liabilities
24
20
18
18
16
19
19
35
44
54
Total Equity
930
1,077
1,264
1,262
1,433
1,542
1,722
1,949
1,981
2,097
Reserve & Surplus
912
1,059
1,246
1,245
1,416
1,525
1,705
1,932
1,964
2,081
Share Capital
18
18
18
18
18
17
17
17
17
16
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-10
1
10
-2
-6
12
-1
5
-11
1
Investing Activities
-89
-73
-144
20
-109
-85
-84
-147
4
-18
Operating Activities
127
171
153
148
104
239
210
162
165
221
Financing Activities
-47
-97
0
-169
-0
-142
-126
-10
-180
-202
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
69.35 %
69.35 %
69.35 %
69.36 %
69.36 %
69.50 %
69.50 %
69.50 %
69.50 %
69.50 %
69.66 %
69.66 %
69.66 %
69.66 %
FIIs
5.71 %
4.76 %
4.51 %
4.47 %
4.52 %
4.34 %
3.99 %
3.77 %
3.80 %
2.06 %
2.42 %
2.43 %
2.65 %
2.51 %
DIIs
4.02 %
4.48 %
4.65 %
5.45 %
5.86 %
6.08 %
6.77 %
7.76 %
8.27 %
9.12 %
8.12 %
7.76 %
6.94 %
6.73 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.92 %
21.40 %
21.48 %
20.72 %
20.27 %
20.09 %
19.74 %
18.98 %
18.43 %
19.32 %
19.80 %
20.15 %
20.76 %
21.10 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
45.40
ATR(14)
Less Volatile
22.35
STOCH(9,6)
Oversold
12.08
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-6.69
ADX(14)
Strong Trend
38.83
UO(9)
Bearish
34.64
ROC(12)
Downtrend But Slowing Down
-9.81
WillR(14)
Oversold
-93.21
Bearish
4
Neutral
2
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.